Tags : Complicated Urinary Tract Infections

Shionogi’s Fetroja (cefiderocol) Receives the US FDA’s Approval for the

Shots: The US FDA approval is based on APEKS-cUTI study assessing Fetroja vs imipenem/cilastatin (IPM/CS) in patients aged ≥18yrs. with cUTI who have limited or no alternative treatment options The pivotal APEKS-cUTI study resulted in higher response rate in microbiological eradication and clinical response at the test of cure (TOC), met its 1EPs (72.6% vs […]Read More